207 related articles for article (PubMed ID: 34837907)
21. Diagnostic significance of miR-106a in gastric cancer.
Hou X; Zhang M; Qiao H
Int J Clin Exp Pathol; 2015; 8(10):13096-101. PubMed ID: 26722506
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
23. hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway.
Gao D; Qi X; Zhang X; Fang K; Guo Z; Li L
Mol Carcinog; 2019 Apr; 58(4):554-564. PubMed ID: 30520151
[TBL] [Abstract][Full Text] [Related]
24. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
26. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
Rao X; Jiang J; Wang Y; Ma X; Liu S
Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
[TBL] [Abstract][Full Text] [Related]
27. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
Zhao FL; Dou YC; Wang XF; Han DC; Lv ZG; Ge SL; Zhang YK
Mol Biol Rep; 2014 Sep; 41(9):5913-22. PubMed ID: 25103018
[TBL] [Abstract][Full Text] [Related]
28. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
29. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
30. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
32. Elevated microRNA-7 inhibits proliferation and tumor angiogenesis and promotes apoptosis of gastric cancer cells via repression of Raf-1.
Lin J; Liu Z; Liao S; Li E; Wu X; Zeng W
Cell Cycle; 2020 Oct; 19(19):2496-2508. PubMed ID: 32931357
[TBL] [Abstract][Full Text] [Related]
33. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
34. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract][Full Text] [Related]
35. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
[TBL] [Abstract][Full Text] [Related]
36. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
[TBL] [Abstract][Full Text] [Related]
38. Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
Sun D; Zhong J; Wei W; Chen X; Liu J; Hu Z
J Gene Med; 2019 Apr; 21(4):e3075. PubMed ID: 30716792
[TBL] [Abstract][Full Text] [Related]
39. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
